Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,649 | -33,727 | -20,761 | -41,519 | -29,156 |
| Depreciation Amortization | 80 | 55 | N/A | 105 | 79 |
| Other Working Capital | 2,621 | 2,690 | 4,577 | 3,656 | 437 |
| Other Operating Activity | 6,682 | 4,464 | 2,232 | 8,910 | 6,635 |
| Operating Cash Flow | $-36,266 | $-26,518 | $-13,952 | $-28,848 | $-22,005 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,562 | 43,544 | 33,589 | 8,316 | -11,040 |
| PPE Investments | -19 | -17 | -6 | -33 | -11 |
| Investing Cash Flow | $8,543 | $43,527 | $33,583 | $8,283 | $-11,051 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,094 | 176 | 140 | 32,119 | 32,095 |
| Financing Cash Flow | $49,094 | $176 | $140 | $32,119 | $32,095 |
| Beginning Cash Position | 25,314 | 25,314 | 25,314 | 13,760 | 13,760 |
| End Cash Position | 46,685 | 42,499 | 45,085 | 25,314 | 12,799 |
| Net Cash Flow | $21,371 | $17,185 | $19,771 | $11,554 | $-961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,266 | -26,518 | -13,952 | -28,848 | -22,005 |
| Capital Expenditure | -19 | -17 | -6 | -33 | -11 |
| Free Cash Flow | -36,285 | -26,535 | -13,958 | -28,881 | -22,016 |